Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis.

Katharina Kurz; Manfred Herold; Christiana Winkler; Werner Klotz; Elisabeth Russe; Dietmar Fuchs

doi:10.3109/08916934.2010.528476

Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis.

Katharina Kurz, Manfred Herold, Christiana Winkler, Werner Klotz, Elisabeth Russe (Co-Autor/-in), Dietmar Fuchs

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

17 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	235-242
Fachzeitschrift	AUTOIMMUNITY
Jahrgang	44
Ausgabenummer	3
DOIs	https://doi.org/10.3109/08916934.2010.528476
Publikationsstatus	Veröffentlicht - 2011

Zugriff auf Dokument

10.3109/08916934.2010.528476

Dieses zitieren

@article{cf2add88ef2640baac6162f0f4c367b0,

title = "Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis.",

keywords = "TUMOR-NECROSIS-FACTOR, SOLUBLE INTERLEUKIN-2 RECEPTOR, FACTOR-ALPHA, TNF-ALPHA, TRYPTOPHAN DEGRADATION, INDOLEAMINE 2,3-DIOXYGENASE, JOINT INFLAMMATION, SYNOVIAL-FLUID, IN-VIVO, CELLS",

author = "Katharina Kurz and Manfred Herold and Christiana Winkler and Werner Klotz and Elisabeth Russe and Dietmar Fuchs",

year = "2011",

doi = "10.3109/08916934.2010.528476",

language = "English",

volume = "44",

pages = "235--242",

journal = "AUTOIMMUNITY",

issn = "0891-6934",

number = "3",

}

TY - JOUR

T1 - Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis.

AU - Kurz, Katharina

AU - Herold, Manfred

AU - Winkler, Christiana

AU - Klotz, Werner

AU - Russe, Elisabeth

AU - Fuchs, Dietmar

PY - 2011

Y1 - 2011

KW - TUMOR-NECROSIS-FACTOR

KW - SOLUBLE INTERLEUKIN-2 RECEPTOR

KW - FACTOR-ALPHA

KW - TNF-ALPHA

KW - TRYPTOPHAN DEGRADATION

KW - INDOLEAMINE 2,3-DIOXYGENASE

KW - JOINT INFLAMMATION

KW - SYNOVIAL-FLUID

KW - IN-VIVO

KW - CELLS

U2 - 10.3109/08916934.2010.528476

DO - 10.3109/08916934.2010.528476

M3 - Original Article

C2 - 21434757

SN - 0891-6934

VL - 44

SP - 235

EP - 242

JO - AUTOIMMUNITY

JF - AUTOIMMUNITY

IS - 3

ER -